Gross Profit Summary of AtriCure, Inc.

AtriCure, Inc.'s latest annual gross profit in 2023 was 300.37 Million USD , up 20.93% from previous year.
AtriCure, Inc.'s latest quarterly gross profit in 2024 Q3 was 86.79 Million USD , up 0.82% from previous quarter.
AtriCure, Inc. reported a annual gross profit of 245.94 Million USD in annual gross profit 2022, up 19.47% from previous year.
AtriCure, Inc. reported a annual gross profit of 205.86 Million USD in annual gross profit 2021, up 37.88% from previous year.
AtriCure, Inc. reported a quarterly gross profit of 86.08 Million USD for 2024 Q2, up 6.9% from previous quarter.
AtriCure, Inc. reported a quarterly gross profit of 86.79 Million USD for 2024 Q3, up 0.82% from previous quarter.

Annual Gross Profit Chart of AtriCure, Inc. (2023 - 2001)

Historical Annual Gross Profit of AtriCure, Inc. (2023 - 2001)

Year	Gross Profit	Gross Profit Growth
2023	300.37 Million USD	20.93%
2022	245.94 Million USD	19.47%
2021	205.86 Million USD	37.88%
2020	149.3 Million USD	-12.34%
2019	170.33 Million USD	15.78%
2018	147.12 Million USD	16.61%
2017	126.16 Million USD	13.56%
2016	111.1 Million USD	19.62%
2015	92.87 Million USD	22.61%
2014	75.75 Million USD	27.18%
2013	59.56 Million USD	19.09%
2012	50.01 Million USD	6.42%
2011	46.99 Million USD	3.54%
2010	45.38 Million USD	8.63%
2009	41.78 Million USD	-0.59%
2008	42.03 Million USD	10.11%
2007	38.17 Million USD	24.68%
2006	30.61 Million USD	33.7%
2005	22.9 Million USD	64.1%
2004	13.95 Million USD	94.37%
2003	7.18 Million USD	561.75%
2002	1.08 Million USD	8941.67%
2001	12 Thousand USD	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	80.53 Million USD	1.84%
2024 Q2	86.08 Million USD	6.9%
2024 Q3	86.79 Million USD	0.82%
2023 Q1	69.6 Million USD	6.9%
2023 Q4	79.07 Million USD	7.05%
2023 FY	297.41 Million USD	20.93%
2023 Q2	77.07 Million USD	10.73%
2023 Q3	73.86 Million USD	-4.16%
2022 Q2	63.51 Million USD	14.25%
2022 Q3	61.71 Million USD	-2.84%
2022 Q4	65.11 Million USD	5.51%
2022 FY	245.94 Million USD	19.47%
2022 Q1	55.59 Million USD	1.05%
2021 Q3	52.22 Million USD	-3.42%
2021 Q1	44.54 Million USD	4.96%
2021 Q2	54.07 Million USD	21.41%
2021 FY	205.86 Million USD	37.88%
2021 Q4	55.01 Million USD	5.34%
2020 Q4	42.43 Million USD	5.21%
2020 FY	149.3 Million USD	-12.34%
2020 Q1	38.88 Million USD	-13.15%
2020 Q2	27.65 Million USD	-28.88%
2020 Q3	40.33 Million USD	45.85%
2019 FY	170.33 Million USD	15.78%
2019 Q2	43.89 Million USD	10.09%
2019 Q3	41.79 Million USD	-4.78%
2019 Q4	44.77 Million USD	7.12%
2019 Q1	39.87 Million USD	3.32%
2018 Q2	38.07 Million USD	10.36%
2018 FY	147.12 Million USD	16.61%
2018 Q4	38.59 Million USD	7.35%
2018 Q3	35.94 Million USD	-5.6%
2018 Q1	34.5 Million USD	5.57%
2017 Q2	32.55 Million USD	8.48%
2017 Q1	30 Million USD	3.84%
2017 FY	126.16 Million USD	13.56%
2017 Q4	32.68 Million USD	5.71%
2017 Q3	30.91 Million USD	-5.03%
2016 Q3	27.47 Million USD	-4.67%
2016 Q1	25.91 Million USD	1.44%
2016 FY	111.1 Million USD	19.62%
2016 Q2	28.81 Million USD	11.21%
2016 Q4	28.89 Million USD	5.19%
2015 Q2	23.11 Million USD	6.36%
2015 FY	92.87 Million USD	22.61%
2015 Q3	22.47 Million USD	-2.76%
2015 Q4	25.54 Million USD	13.64%
2015 Q1	21.73 Million USD	6.44%
2014 Q1	17.65 Million USD	12.69%
2014 FY	75.75 Million USD	27.18%
2014 Q2	18.78 Million USD	6.37%
2014 Q4	20.42 Million USD	8.09%
2014 Q3	18.89 Million USD	0.59%
2013 Q2	15.12 Million USD	7.36%
2013 Q1	14.08 Million USD	8.34%
2013 Q4	15.66 Million USD	6.7%
2013 Q3	14.68 Million USD	-2.9%
2013 FY	59.56 Million USD	19.09%
2012 Q3	11.54 Million USD	-9.14%
2012 Q4	13 Million USD	12.58%
2012 Q2	12.71 Million USD	-0.32%
2012 FY	50.01 Million USD	6.42%
2012 Q1	12.75 Million USD	8.61%
2011 Q1	11.89 Million USD	-3.36%
2011 Q4	11.74 Million USD	5.91%
2011 FY	46.99 Million USD	3.54%
2011 Q3	11.08 Million USD	-9.71%
2011 Q2	12.27 Million USD	3.23%
2010 Q4	12.3 Million USD	10.13%
2010 Q2	11.22 Million USD	5.15%
2010 Q3	11.17 Million USD	-0.49%
2010 Q1	10.67 Million USD	2.88%
2010 FY	45.38 Million USD	8.63%
2009 Q1	10.72 Million USD	19.7%
2009 Q4	10.38 Million USD	3.77%
2009 Q3	10 Million USD	-6.25%
2009 Q2	10.67 Million USD	-0.55%
2009 FY	41.78 Million USD	-0.59%
2008 Q3	11.4 Million USD	0.37%
2008 FY	42.03 Million USD	10.11%
2008 Q1	10.29 Million USD	-2.22%
2008 Q2	11.36 Million USD	10.33%
2008 Q4	8.96 Million USD	-21.41%
2007 Q1	8.54 Million USD	3.59%
2007 FY	38.17 Million USD	24.68%
2007 Q2	9.8 Million USD	14.81%
2007 Q4	10.53 Million USD	13.33%
2007 Q3	9.29 Million USD	-5.21%
2006 FY	30.61 Million USD	33.7%
2006 Q1	7.03 Million USD	9.69%
2006 Q2	7.86 Million USD	11.75%
2006 Q3	7.47 Million USD	-4.98%
2006 Q4	8.24 Million USD	10.33%
2005 Q3	5.15 Million USD	-10.4%
2005 Q4	6.41 Million USD	24.47%
2005 Q1	5.57 Million USD	33.9%
2005 FY	22.9 Million USD	64.1%
2005 Q2	5.75 Million USD	3.12%
2004 FY	13.95 Million USD	94.37%
2004 Q4	4.16 Million USD	24.8%
2004 Q2	3.73 Million USD	0.0%
2004 Q3	3.33 Million USD	-10.73%
2003 FY	7.18 Million USD	561.75%
2002 FY	1.08 Million USD	8941.67%
2001 FY	12 Thousand USD	0.0%

Peer Gross Profit Comparison of AtriCure, Inc.

Name	Gross Profit	Gross Profit Difference
Akoya Biosciences, Inc.	56.3 Million USD	-433.469%
AngioDynamics, Inc.	154.69 Million USD	-94.165%
Avinger, Inc.	2 Million USD	-14896.006%
Azenta, Inc.	263.14 Million USD	-14.148%
BioLife Solutions, Inc.	46.75 Million USD	-542.475%
The Cooper Companies, Inc.	2.35 Billion USD	87.261%
Daxor Corporation	1.1 Million USD	-27121.235%
Ekso Bionics Holdings, Inc.	9.07 Million USD	-3208.404%
Femasys Inc.	691.9 Thousand USD	-43312.28%
GlucoTrack, Inc.	-13 Thousand USD	2310638.462%
Harvard Bioscience, Inc.	60.86 Million USD	-393.494%
Hologic, Inc.	2.22 Billion USD	86.517%
ICU Medical, Inc.	739.87 Million USD	59.402%
Intuitive Surgical, Inc.	4.72 Billion USD	93.649%
KORU Medical Systems, Inc.	16.7 Million USD	-1697.731%
LeMaitre Vascular, Inc.	127.04 Million USD	-136.421%
Innovative Eyewear, Inc.	-119.32 Thousand USD	251815.844%
Innovative Eyewear, Inc.	-119.32 Thousand USD	251815.844%
Masimo Corporation	1 Billion USD	70.068%
Microbot Medical Inc.	-106 Thousand USD	283467.925%
Meihua International Medical Technologies Co., Ltd.	33.09 Million USD	-807.599%
Merit Medical Systems, Inc.	583.87 Million USD	48.556%
Nephros, Inc.	8.4 Million USD	-3473.706%
NovoCure Limited	381.05 Million USD	21.175%
NEXGEL, Inc.	619 Thousand USD	-48425.04%
NEXGEL, Inc.	619 Thousand USD	-48425.04%
Singular Genomics Systems, Inc.	-558 Thousand USD	53929.749%
OraSure Technologies, Inc.	179.42 Million USD	-67.411%
Pro-Dex, Inc.	14.55 Million USD	-1964.257%
Pulse Biosciences, Inc.	-1.2 Million USD	24985.667%
Predictive Oncology Inc.	1.14 Million USD	-26126.385%
Precision Optics Corporation, Inc.	5.79 Million USD	-5080.779%
QuidelOrtho Corporation	1.49 Billion USD	79.9%
Repligen Corporation	315.22 Million USD	4.713%
Sanara MedTech Inc.	57.13 Million USD	-425.7%
STAAR Surgical Company	252.65 Million USD	-18.887%
Sharps Technology, Inc.	-891.24 Thousand USD	33802.179%
Utah Medical Products, Inc.	30.03 Million USD	-899.967%
DENTSPLY SIRONA Inc.	2.08 Billion USD	85.601%
Jin Medical International Ltd.	6.78 Million USD	-4327.08%

Global Stocks Search

AtriCure, Inc. (ATRC)

Gross Profit Summary of AtriCure, Inc.

Annual Gross Profit Chart of AtriCure, Inc. (2023 - 2001)

Historical Annual Gross Profit of AtriCure, Inc. (2023 - 2001)

Peer Gross Profit Comparison of AtriCure, Inc.